| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.081 | 0.06 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.077 | 0.08 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.075 | 0.09 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.039 | 0.4 |